SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-236159
Filing Date
2023-09-15
Accepted
2023-09-15 16:06:02
Documents
12
Period of Report
2023-09-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d482013d8k.htm   iXBRL 8-K 23582
  Complete submission text file 0001193125-23-236159.txt   144987

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nexi-20230911.xsd EX-101.SCH 2827
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20230911_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20230911_pre.xml EX-101.PRE 11243
6 EXTRACTED XBRL INSTANCE DOCUMENT d482013d8k_htm.xml XML 3340
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 231258736
SIC: 2834 Pharmaceutical Preparations